Home / FlashMed
FlashMed
Titolo | Diuretic use, residual renal function, and mortality among Hemodialysis Patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS) |
Autore | J.L. Bragg-Gresham, R.B. Fissell, N.A. Mason, G.R. Bailie, B.W. Gillespie, V. Wizemann, J.M. Cruz, T. Akiba, K. Kurokawa, S. Ramirez, E.W. Young |
Referenza | Am J Kidney Dis 2007; 49: 426-431 |
Contenuto | Background: Information about residual renal function (RRF) and outcomes associated with practices of diuretic use in patients with end-stage renal disease is not available worldwide. Methods: Diuretic use was investigated in 16,420 hemodialysis patients from the Dialysis Outcomes and Practice Patterns Study, a prospective observational study of hemodialysis patients selected from nationally representative facilities on 3 continents. Logistic regressions were used to investigateassociations between diuretic use and patient characteristics. Outcomes of interdialytic weight gain, increased serum potassium and phosphorus levels, and odds of retaining RRF after 1 year were investigated. Cox regression was used to analyze the association between mortality and diuretic use. Results: Facility diuretic use varied substantially from 0% to 83.9% of patients. Diuretic use decreased sharply after the start of dialysis therapy. Loop diuretic use ranged from 9.2% in the United States to 21.3% in Europe, whereas use within 90 days of starting dialysis therapy ranged from 25.0% in the United States to 47.6% in Japan. Diuretic use was associated with lower interdialytic weight gain and lower odds of hyperkalemia (potassium _ 6.0 mmol/L). Patients with RRF on diuretic therapy had almost twice the odds of retaining RRF after 1 year in the study versus patients not on diuretic therapy. Patients administered diuretics had a 7% lower all-cause mortality risk (P _ 0.12) and 14% lower cardiac-specific mortality risk (P _ 0.03) versus patients not administered diuretics. Conclusion: Variation exists in facility practices of diuretic use. In patients with RRF, there may be benefit associated with continuing diuretic use rather than automatically discontinuing diuretic therapy at dialysis initiation. |
Data | 26.03.2007 |
Lista completa |
|